Kilitch Drugs (India) Ltd Share Price
(KILITCH)
₹362.6▲6.1%
as on 04:01PM, 28 Mar 2025
Kilitch Drugs (India) Ltd Performance
Day's Low
Day's High
₹342.2Day's Price Range₹367.552 Week's Low
52 Week's High
₹30052-Week Price Range₹404.95
| Returns % | |
| 1 Month Return | + 15.09 % |
| 3 Month Return | + 14.22 % |
| 1 Year Return | -4.97 % |
| Market Stats | |
| Previous Close | ₹341.75 |
| Open | ₹347.45 |
| Volume | 19.38K |
| Upper Circuit | ₹410.10 |
| Lower Circuit | ₹273.40 |
| Market Cap | ₹583.14Cr |
Kilitch Drugs (India) Ltd Fundamentals
P/E Ratio
29.87
PEG Ratio
10.23
Market Cap
₹583.14 Cr
P/B Ratio
2.81
EPS
8.44
Dividend Yield
0Sector
Pharmaceuticals
ROE
8.39
Key events for Kilitch Drugs (India) Ltd
Kilitch Drugs Reports Strong Growth and Expansion Plans - 19 Mar, 2025
Kilitch Drugs Ltd plans to enter biosimilars and expand manufacturing in Maharashtra. The company expects ₹200 crore revenue this year, reporting a 222% YoY profit rise in Q3FY25.
Insights on Kilitch Drugs (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 30.76% to 30.77% in Dec 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, KILITCH stock has moved up by 14.2%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 36.03 Cr → 57.89 Cr (in ₹), with an average increase of 20.3% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.8% return, outperforming this stock by 13.2%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.23% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 61.9% return, outperforming this stock by 66.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 8.62 Cr → 5.96 Cr (in ₹), with an average decrease of 30.9% per quarter
Kilitch Drugs (India) Ltd Financials
Kilitch Drugs (India) Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.23% | 0.00 | |
| Foreign Institutions | 0% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 30.77% | 0.01 | |
| Others | 0% | 0.00 |
Kilitch Drugs (India) Ltd Key Indicators
Kilitch Drugs (India) Ltd Valuation
Kilitch Drugs (India) Ltd in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (29.87x)
March 28, 2025
Industry (53.18x)
March 28, 2025
Highest (363.79x)
October 16, 2020
Kilitch Drugs (India) Ltd Earnings and Dividends
Kilitch Drugs (India) Ltd Earnings Results
Kilitch Drugs (India) Ltd’s net profit jumped 104.81% since last year same period to ₹5.96Cr in the Q3 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -30.86% fall in its net profits since last 3-months.
Read More about Earnings ResultsKilitch Drugs (India) Ltd Dividends May,2019
In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.14%.
Read More about Dividends
Kilitch Drugs (India) Ltd Technicals Summary
Bearish
Neutral
Bullish
Kilitch Drugs (India) Ltd is currently in a Bullish trading position according to technical analysis indicators.
Kilitch Drugs (India) Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹583.14 Cr | 71.28% | 0.56 | ₹13 Cr | ₹154 Cr | |
| NA | ₹22.46 Cr | 78.35% | 0.50 | NA | NA | |
| NA | ₹1,923.52 Cr | 980.26% | 0.54 | ₹36 Cr | ₹295 Cr | |
| NA | ₹901.74 Cr | 648.5% | 0.65 | ₹23 Cr | ₹307 Cr | |
| NA | ₹117.60 Cr | 31.24% | 0.72 | -₹10 Cr | ₹368 Cr |
About Kilitch Drugs (India) Ltd
Revenue: ₹56.17Cr as on December 2024 (Q4 24)
Net Profit: ₹5.61Cr as on December 2024 (Q4 24)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
| Organisation | Kilitch Drugs (India) Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Kilitch Drugs (India) Ltd
What is Kilitch Drugs (India) Ltd price today?
Kilitch Drugs (India) Ltd share price today stands at ₹362.6, Open: ₹347.45, Previous Close: ₹341.75, High: ₹367.5, Low: ₹342.2, 52 Week High: ₹404.95, 52 Week Low: ₹300.
How to Buy Kilitch Drugs (India) Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Kilitch Drugs (India) Ltd shares
What are today's traded volumes of Kilitch Drugs (India) Ltd?
Today's traded volume of Kilitch Drugs (India) Ltd(KILITCH) is 19.38K.
What is today's market capitalisation of Kilitch Drugs (India) Ltd?
Today's market capitalisation of Kilitch Drugs (India) Ltd(KILITCH) is ₹583.14Cr.
What is the 52 Week High and Low Range of Kilitch Drugs (India) Ltd?
How much percentage Kilitch Drugs (India) Ltd is down from its 52 Week High?
Kilitch Drugs (India) Ltd (KILITCH) share price is ₹362.6. It is down -10.46% from its 52 Week High price of ₹404.95
How much percentage Kilitch Drugs (India) Ltd is up from its 52 Week low?
Kilitch Drugs (India) Ltd (KILITCH) share price is ₹362.6. It is up 20.87% from its 52 Week Low price of ₹300